Evidence map›Paper›PMID 36500209›Full record

ReviewMolecules (Basel, Switzerland)2022

Cyclo- and Polyphosphazenes for Biomedical Applications.

Girolamo Casella, Silvia Carlotto, Francesco Lanero, Mirto Mozzon, Paolo Sgarbossa, Roberta Bertani

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Girolamo CasellaDepartment of Earth and Marine Sciences (DiSTeM), University of Palermo, Via Archirafi 22, 90123 Palermo, Italy.ORCID 0000-0002-8471-0848
Silvia CarlottoDepartment of Chemical Sciences (DiSC), University of Padova, Via F. Marzolo 1, 35131 Padova, Italy.ORCID 0000-0003-0043-3538
Francesco LaneroDepartment of Industrial Engineering, University of Padova, Via F. Marzolo 1, 35131 Padova, Italy.ORCID 0000-0001-7665-3209
Mirto MozzonDepartment of Industrial Engineering, University of Padova, Via F. Marzolo 1, 35131 Padova, Italy.
Paolo SgarbossaDepartment of Industrial Engineering, University of Padova, Via F. Marzolo 1, 35131 Padova, Italy.ORCID 0000-0002-0938-953X
Roberta BertaniDepartment of Industrial Engineering, University of Padova, Via F. Marzolo 1, 35131 Padova, Italy.ORCID 0000-0003-3058-7546
University of Padua · ITUniversity of Palermo · IT

Funding

Department of Industrial Engineering, University of Padova (Italy). SID Project 2022
6 · The paper itself

Abstract

Cyclic and polyphosphazenes are extremely interesting and versatile substrates characterized by the presence of -P=N- repeating units. The chlorine atoms on the P atoms in the starting materials can be easily substituted with a variety of organic substituents, thus giving rise to a huge number of new materials for industrial applications. Their properties can be designed considering the number of repetitive units and the nature of the substituent groups, opening up to a number of peculiar properties, including the ability to give rise to supramolecular arrangements. We focused our attention on the extensive scientific literature concerning their biomedical applications: as antimicrobial agents in drug delivery, as immunoadjuvants in tissue engineering, in innovative anticancer therapies, and treatments for cardiovascular diseases. The promising perspectives for their biomedical use rise from the opportunity to combine the benefits of the inorganic backbone and the wide variety of organic side groups that can lead to the formation of nanoparticles, polymersomes, or scaffolds for cell proliferation. In this review, some aspects of the preparation of phosphazene-based systems and their characterization, together with some of the most relevant chemical strategies to obtain biomaterials, have been described.

Indexed as

Biocompatible MaterialsPolymersOrganophosphorus CompoundsTissue EngineeringBiocompatible MaterialsOrganophosphorus CompoundsPolymerspoly(phosphazene)cyclophosphazenesdrug deliverypolyphosphazenestissue engineering

Identifiers

PMID36500209
PMCPMC9736570
OpenAlexW4309570541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.